These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24679107)

  • 41. Antimicrobial resistance of genital mycoplasmas recovered from nonpregnant women in Greece: trends over the last 15 years.
    Koumaki V; Chasiakou A; Kantzanou M; Tsakris A; Baka S
    Future Microbiol; 2024 Jul; 19(10):867-875. PubMed ID: 38629933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.
    Bébéar CM; de Barbeyrac B; Pereyre S; Renaudin H; Clerc M; Bébéar C
    Clin Microbiol Infect; 2008 Aug; 14(8):801-5. PubMed ID: 18727805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance to tetracyclines among clinical isolates of Mycoplasma hominis and Ureaplasma species: a systematic review and meta-analysis.
    Ahmadi MH
    J Antimicrob Chemother; 2021 Mar; 76(4):865-875. PubMed ID: 33367765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial resistance rates of urogenital Mycoplasma hominis and Ureaplasma species before and during the COVID-19 pandemic: results from a Greek survey, 2014 to 2022.
    Akinosoglou K; Tsiakalos A; Dimopoulou ID; Schinas G; Polyzou E; Kourea-Kremastinou J; Pitiriga VC
    J Antibiot (Tokyo); 2024 Feb; 77(2):120-125. PubMed ID: 38017085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial Susceptibility Patterns of Ureaplasma urealyticum and Mycoplasma hominis Isolated From Pregnant Women.
    Azizmohammadi S; Azizmohammadi S
    Iran Red Crescent Med J; 2015 Dec; 17(12):e17211. PubMed ID: 26756001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiological investigation and antimicrobial susceptibility analysis of mycoplasma in patients with genital manifestations.
    Gu X; Liu S; Guo X; Weng R; Zhong Z
    J Clin Lab Anal; 2020 Apr; 34(4):e23118. PubMed ID: 31721313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and Antimicrobial Resistance of Ureaplasma urealyticum and Mycoplasma hominis in Patients with Genital Tract Infection in Jiangsu, China.
    Luo R; Xun K; Zuo L; Sha F; Chen Y; Yu N; Jin D; Xie Y; He M; Liu F
    Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and Antimicrobial Susceptibility of Mycoplasma hominis and
    Lee JY; Yang JS
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32718969
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Chinese women with genital infectious diseases.
    Zhu C; Liu J; Ling Y; Dong C; Wu T; Yu X; Hou Y; Dong L; Cheng X
    Indian J Dermatol Venereol Leprol; 2012; 78(3):406-7. PubMed ID: 22565456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board.
    Horner P; Donders G; Cusini M; Gomberg M; Jensen JS; Unemo M
    J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1845-1851. PubMed ID: 29924422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ureaplasma urealyticum and Mycoplasma hominis sensitivity to bacteriocins produced by two Lactobacilli strains.
    Daniele M; Ruiz F; Pascual L; Barberis L
    Curr Microbiol; 2011 Oct; 63(4):360-5. PubMed ID: 21805206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2604-8. PubMed ID: 11502536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
    Waites KB; Crabb DM; Duffy LB
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3776-8. PubMed ID: 18663020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas.
    Waites KB; Crabb DM; Liu Y; Duffy LB
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7502-7504. PubMed ID: 27671057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mycoplasma hominis increases the risk for Ureaplasma parvum infection in Human immunodeficiency virus infected pregnant women.
    Nundlall N; Ngobese B; Singh R; Tinarwo P; Abbai N
    J Infect Dev Ctries; 2024 Feb; 18(2):258-265. PubMed ID: 38484352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in patients with non-gonococcal urethritis using polymerase chain reaction-microtiter plate hybridization.
    Maeda S; Deguchi T; Ishiko H; Matsumoto T; Naito S; Kumon H; Tsukamoto T; Onodera S; Kamidono S
    Int J Urol; 2004 Sep; 11(9):750-4. PubMed ID: 15379939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tetracycline resistance in Ureaplasma spp. and Mycoplasma hominis: prevalence in Bordeaux, France, from 1999 to 2002 and description of two tet(M)-positive isolates of M. hominis susceptible to tetracyclines.
    Dégrange S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2008 Feb; 52(2):742-4. PubMed ID: 18025113
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Waites KB; Crabb DM; Xiao L; Duffy LB; Leal SM
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency and antimicrobial sensitivity of Ureaplasma urealyticum and Mycoplasma hominis in patients with vaginal discharge.
    Díaz L; Cabrera LE; Fernández T; Ibáñez I; Torres Y; Obregón Y; Rivero Y
    MEDICC Rev; 2013 Oct; 15(4):45-7. PubMed ID: 24253351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse pregnancy and birth outcomes associated with
    Jonduo ME; Vallely LM; Wand H; Sweeney EL; Egli-Gany D; Kaldor J; Vallely AJ; Low N
    BMJ Open; 2022 Aug; 12(8):e062990. PubMed ID: 36028274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.